Is the business good?
How good a business is PFE?
Pfizer keeps 6.8% of every revenue dollar as profit after everything, against 18% for the median Drug Manufacturers - General name.
6.8%
Net margin · Drug Manufacturers - General median 18% · 12 months to Q2 2026
- Cash conversion
- 2.54×
Cash conversion · 1.16× a year ago · every dollar of reported profit arrived as cash, and more
- Share count, year on year
- −0.12%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 17%
R&D as % of revenue
Details›
- Gross margin12 months to Q2 2026
- 73%
- Net margin12 months to Q2 2026
- 6.8%
- Free cash flow margin
- 17%
- R&D as % of revenue
- 17%
- Revenue, trailing twelve months
- $63.7B
- Free cash flow, trailing twelve months
- $11.0B
- Net income, trailing twelve months
- $4.33B
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Drug Manufacturers - General
Ranks #14 of 16 by Smart Score